返回 Agenda
Session Chair(s)
David H. Schubert
DH Schubert Regulatory Solutions LLC, United States
Speaker(s)
A Case Study of Challenges Faced during Early Stage Oligo Development
Doug Kornbrust, PhD
Preclinsight, United States
President
Decisions During Mid-Stage Development
Akshay K. Vaishnaw, MD, PhD
Alnylam Pharmaceuticals, Inc., United States
Chief Medical Officer
Late Phase Development Issues
Mike L. Webb
GlaxoSmithKline, United Kingdom
Vice President, API Chemistry & Analysis